Pharmacotherapy considerations in transgender individuals living with human immunodeficiency virus.
Pharmacotherapy
; 41(3): 299-314, 2021 03.
Article
in En
| MEDLINE
| ID: mdl-33404067
ABSTRACT
Pharmacotherapy considerations are often a concern for transgender individuals who are living with human immunodeficiency virus (HIV) due to concerns for drug-drug interactions between their hormone and antiretroviral therapies. Many of the first-line therapies offered to patients for the management of HIV have reduced concerns for safety, resistance, and drug-drug interactions. In this review, we highlight common medications and important considerations for caring for transgender people living with HIV.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
HIV Infections
/
Transgender Persons
Limits:
Female
/
Humans
/
Male
Language:
En
Journal:
Pharmacotherapy
Year:
2021
Document type:
Article
Affiliation country:
United States